Orient EuroPharma Co., Ltd. (TPEX:4120)

Orient EuroPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,986	1,435	1,736	1,801	1,959	2,121
Short-Term Investments	84.14	174.26	159.52	70.8	80.8	201.8
Cash & Short-Term Investments	2,070	1,609	1,896	1,872	2,040	2,323
Cash Growth	33.88%	-15.10%	1.27%	-8.25%	-12.19%	26.68%
Accounts Receivable	813.45	847.2	783.01	730.48	580.03	524.06
Other Receivables	38.83	21.44	26.94	27.66	33.53	18.17
Receivables	852.28	868.64	809.94	758.15	613.55	542.23
Inventory	1,191	1,065	1,147	1,304	1,082	1,350
Prepaid Expenses	215.18	137.26	118.23	162.21	136.07	87.96
Other Current Assets	83.88	295.84	257.28	88.62	53.63	13.89
Total Current Assets	4,412	3,976	4,228	4,185	3,925	4,317
Property, Plant & Equipment	3,842	3,851	3,986	4,019	4,181	2,894
Long-Term Investments	2,757	2,296	1,064	533.57	416.83	191.06
Other Intangible Assets	45.91	43.76	42.69	43.01	78.16	104.48
Long-Term Deferred Tax Assets	584.91	623.1	677.16	588.05	631.87	522.46
Other Long-Term Assets	786.26	780.13	814.28	1,062	170.82	130.57
Total Assets	12,428	11,570	10,812	10,430	9,403	8,160
Accounts Payable	264.06	176.13	348.07	552.2	159.81	318.76
Accrued Expenses	311.57	296.94	274.85	353.04	390.66	456.17
Short-Term Debt	1,426	2,112	2,324	2,191	2,050	1,225
Current Portion of Long-Term Debt	227.7	379.89	272.31	350.18	246.82	158.57
Current Portion of Leases	33.53	38.79	41.95	44.06	25.78	32.41
Current Income Taxes Payable	155.48	20.21	138.39	16.02	55.52	13.76
Other Current Liabilities	248.71	283.6	312.65	286.42	303.12	224.54
Total Current Liabilities	2,668	3,308	3,712	3,793	3,232	2,429
Long-Term Debt	861.6	1,343	1,790	1,991	1,680	758.28
Long-Term Leases	318.11	354.37	412.89	447.92	218.46	229.47
Pension & Post-Retirement Benefits	45.03	47	58.69	59.82	66.99	65.14
Long-Term Deferred Tax Liabilities	622.74	670.13	651.99	671.26	728.29	746.01
Other Long-Term Liabilities	21.93	22.9	23.44	23.3	24.65	26.83
Total Liabilities	4,537	5,746	6,649	6,987	5,950	4,255
Common Stock	867.47	867.47	867.47	867.47	867.47	867.47
Additional Paid-In Capital	518.46	271.26	271.26	271.26	263.44	260.77
Retained Earnings	3,907	2,046	1,752	1,738	2,118	2,274
Comprehensive Income & Other	1,563	1,979	624.12	51.9	-307.04	-193.43
Total Common Equity	6,857	5,164	3,514	2,929	2,942	3,209
Minority Interest	1,034	660.39	648	514.77	511.39	696.34
Shareholders' Equity	7,891	5,824	4,162	3,444	3,453	3,905
Total Liabilities & Equity	12,428	11,570	10,812	10,430	9,403	8,160
Total Debt	2,867	4,229	4,841	5,024	4,221	2,403
Net Cash (Debt)	-797.59	-2,620	-2,946	-3,153	-2,181	-80.19
Net Cash Per Share	-9.19	-30.20	-33.88	-36.34	-25.08	-0.92
Filing Date Shares Outstanding	86.75	86.75	86.75	86.75	86.75	86.75
Total Common Shares Outstanding	86.75	86.75	86.75	86.75	86.75	86.75
Working Capital	1,745	667.71	515.42	391.79	693.29	1,888
Book Value Per Share	79.04	59.53	40.51	33.76	33.91	36.99
Tangible Book Value	6,811	5,120	3,472	2,886	2,864	3,104
Tangible Book Value Per Share	78.51	59.03	40.02	33.27	33.01	35.78
Land	1,150	1,157	1,169	1,169	1,462	578.12
Buildings	2,300	2,300	2,347	2,243	2,190	1,754
Machinery	1,106	1,083	1,069	992.9	965.5	918.07
Construction In Progress	116.24	27.78	3.55	36.12	48.41	0.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.